March 19, 2014
The Japanese Society of Hematology will set up an investigation panel to look into a scandal-rocked clinical trial involving Tasigna (nilotinib), Novartis Pharma’s chronic myeloid leukemia (CML) drug. The society said on March 17 that the panel will examine whether...read more